The University of British Columbia recently published an article in the peer-reviewed. medical journal The Annals of Medicine questioning the efficacy of Gardasil, the vaccine currently administered to prevent Human papillomavirus (HPV). The authors found many issues with the use of Gardasil in Canada, including:
1) " ...while the world's leading medical authorities state that HPV vaccines are an important cervical cancer prevention tool, clinical trials show no evidence that HPV vaccination can protect against cervical cancer."
2) " ...contrary to claims that cervical cancer is the second most common cancer in women worldwide, existing data show that this only applies to developing countries."
3) Last but not least, they say "...cervical cancer is a rare disease with mortality rates that are several times lower than the rate of reported serious adverse reactions (including deaths) from HPV vaccination."